SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 598 filers reported holding SEAGEN INC in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $81,399,197 | +9.5% | 383,687 | -0.7% | 0.07% | +15.5% |
Q2 2023 | $74,351,532 | -17.9% | 386,322 | -13.6% | 0.06% | -13.4% |
Q1 2023 | $90,571,715 | +57.5% | 447,334 | -0.0% | 0.07% | +45.7% |
Q4 2022 | $57,488,049 | -8.3% | 447,343 | -2.4% | 0.05% | -11.5% |
Q3 2022 | $62,712,000 | -22.9% | 458,318 | -0.3% | 0.05% | -17.5% |
Q2 2022 | $81,372,000 | +26.0% | 459,882 | +2.6% | 0.06% | +46.5% |
Q1 2022 | $64,574,000 | -10.1% | 448,278 | -3.5% | 0.04% | -2.3% |
Q4 2021 | $71,833,000 | +0.9% | 464,636 | +10.9% | 0.04% | 0.0% |
Q3 2021 | $71,169,000 | +1.9% | 419,137 | -5.2% | 0.04% | +7.3% |
Q2 2021 | $69,817,000 | +13.2% | 442,213 | -0.4% | 0.04% | +5.1% |
Q1 2021 | $61,656,000 | -38.1% | 444,013 | -22.0% | 0.04% | -39.1% |
Q4 2020 | $99,655,000 | – | 569,002 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |